药物对比
Dapagliflozin vs Pioglitazone
Dapagliflozin 与 Pioglitazone 对比：Farxiga（SGLT2）与 Actos（TZD）治疗糖尿病。心脏/肾脏保护与胰岛素抵抗治疗及心力衰竭风险。
此页面暂无可用的对比维度。
临床背景
This comparison arises when selecting add-on oral therapy for type 2 diabetes patients with or at risk for heart failure or chronic kidney disease.
结论
Dapagliflozin typically provides broader cardioprotective and renal benefits compared to pioglitazone, which has notable heart failure risks.
全部药物对比